Skip to main content
Top
Published in: Supportive Care in Cancer 7/2020

Open Access 01-07-2020 | Breast Cancer | Original Article

Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completion

Authors: J. M. Admiraal, J. E. H. M. Hoekstra-Weebers, C. P. Schröder, W. Tuinier, G. A. P. Hospers, Anna K. L. Reyners

Published in: Supportive Care in Cancer | Issue 7/2020

Login to get access

Abstract

Purpose

We examined distress levels, problems, referral wish, and supportive health care use in a cross-sectional group of breast cancer survivors at two-time points with a 1-year time interval. Also, factors related to continuing elevated distress were explored.

Methods

Breast cancer survivors, 1–5 years after chemotherapy completion, filled in the Dutch Distress Thermometer/Problem List (DT/PL) and questions on background characteristics at study inclusion (T1). DT/PL responses and health care use were discussed during semi-structured interviews. One year later, re-assessment took place (T2). The data were analyzed by descriptive and univariate analyses. Continuing elevated distress was defined as a DT score ≥ 5 at T1 and T2.

Results

Seventy-three survivors completed all questionnaires (response = 84.6%). Eighteen (25%) experienced continuing elevated distress. Fatigue (T1 N = 48 (66%); T2 N = 41 (56%)) and lack of physical fitness (T1 N = 44 (60%); T2 N = 36 (49%)) were most often reported. Time since diagnosis, health care use, and practical, social, emotional and physical problems were significantly associated with continuing elevated distress. Between diagnosis and T1, N = 49(67%) used supportive healthcare services, mostly a psychologist and/or a physical/lymphedema therapist, and between T1 and T2, 39 (53%) did. At T1, 8 (11%) expressed a referral wish and at T2, 11 (16%) did.

Conclusions

Screening and management of distress, problems, and referral wish are important, even years after chemotherapy completion as a substantial proportion of breast cancer survivors continue to report elevated distress and problems. Special attention should be paid to survivors reporting physical problems, especially fatigue and lack of physical fitness, since these problems are most strongly related to continuing elevated distress.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRef
3.
go back to reference Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H (2005) Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 23:4945–4953CrossRef Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H (2005) Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 23:4945–4953CrossRef
4.
go back to reference Hartl K, Engel J, Herschbach P, Reinecker H, Sommer H, Friese K (2010) Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors. Psychooncology 19:160–169CrossRef Hartl K, Engel J, Herschbach P, Reinecker H, Sommer H, Friese K (2010) Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors. Psychooncology 19:160–169CrossRef
5.
go back to reference Knobf MT (2011) Clinical update: psychosocial responses in breast cancer survivors. Semin Oncol Nurs 27:e1–e14CrossRef Knobf MT (2011) Clinical update: psychosocial responses in breast cancer survivors. Semin Oncol Nurs 27:e1–e14CrossRef
6.
go back to reference Stanton AL (2012) What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol 30:1215–1220CrossRef Stanton AL (2012) What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol 30:1215–1220CrossRef
7.
go back to reference Carlson LE, Bultz BD (2003) Cancer distress screening. Needs, models, and methods. J Psychosom Res 55:403–409CrossRef Carlson LE, Bultz BD (2003) Cancer distress screening. Needs, models, and methods. J Psychosom Res 55:403–409CrossRef
8.
go back to reference Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE (2008) Screening and referral for psychosocial distress in oncologic practice: use of the distress thermometer. Cancer 113:870–878CrossRef Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE (2008) Screening and referral for psychosocial distress in oncologic practice: use of the distress thermometer. Cancer 113:870–878CrossRef
9.
go back to reference Admiraal JM, Reyners AK, Hoekstra-Weebers JE (2013) Do cancer and treatment type affect distress? Psychooncology 22:1766–1773CrossRef Admiraal JM, Reyners AK, Hoekstra-Weebers JE (2013) Do cancer and treatment type affect distress? Psychooncology 22:1766–1773CrossRef
11.
go back to reference Shim EJ, Mehnert A, Koyama A, Cho SJ, Inui H, Paik NS, Koch U (2006) Health-related quality of life in breast cancer: a cross-cultural survey of German, Japanese, and South Korean patients. Breast Cancer Res Treat 99:341–350CrossRef Shim EJ, Mehnert A, Koyama A, Cho SJ, Inui H, Paik NS, Koch U (2006) Health-related quality of life in breast cancer: a cross-cultural survey of German, Japanese, and South Korean patients. Breast Cancer Res Treat 99:341–350CrossRef
12.
go back to reference Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuro-Oncol 57:41–49CrossRef Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuro-Oncol 57:41–49CrossRef
13.
go back to reference Von Essen L, Larsson G, Oberg K, Sjoden PO (2002) ‘Satisfaction with care’: associations with health-related quality of life and psychosocial function among Swedish patients with endocrine gastrointestinal tumours. Eur J Cancer Care (Engl) 11:91–99CrossRef Von Essen L, Larsson G, Oberg K, Sjoden PO (2002) ‘Satisfaction with care’: associations with health-related quality of life and psychosocial function among Swedish patients with endocrine gastrointestinal tumours. Eur J Cancer Care (Engl) 11:91–99CrossRef
14.
go back to reference Kennard BD, Stewart S, Olvera R, Bawdon RE, Hailin AE, Lewis CP, Winick NJ (2004) Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome. J Clin Psychol Med Settings 11:31–39CrossRef Kennard BD, Stewart S, Olvera R, Bawdon RE, Hailin AE, Lewis CP, Winick NJ (2004) Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome. J Clin Psychol Med Settings 11:31–39CrossRef
15.
go back to reference Henselmans I, Helgeson VS, Seltman H, de Vries J, Sanderman R, Ranchor AV (2010) Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol 29:160–168CrossRef Henselmans I, Helgeson VS, Seltman H, de Vries J, Sanderman R, Ranchor AV (2010) Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol 29:160–168CrossRef
16.
go back to reference Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, Reyners AK, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Sprangers MA (2016) Predictors of enduring clinical distress in women with breast cancer. Breast Cancer Res Treat 158:563–572CrossRef Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, Reyners AK, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Sprangers MA (2016) Predictors of enduring clinical distress in women with breast cancer. Breast Cancer Res Treat 158:563–572CrossRef
17.
go back to reference Hoffman BM, Zevon MA, D’Arrigo MC, Cecchini TB (2004) Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology 13:792–799CrossRef Hoffman BM, Zevon MA, D’Arrigo MC, Cecchini TB (2004) Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology 13:792–799CrossRef
18.
go back to reference Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, Zhou M, Sang Y, Jiang Y, Liu L (2014) The diagnostic role of a short screening tool--the distress thermometer: a meta-analysis. Support Care Cancer 22:1741–1755CrossRef Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, Zhou M, Sang Y, Jiang Y, Liu L (2014) The diagnostic role of a short screening tool--the distress thermometer: a meta-analysis. Support Care Cancer 22:1741–1755CrossRef
20.
go back to reference Klinkhammer-Schalke M, Koller M, Steinger B, Ehret C, Ernst B, Wyatt JC, Hofstadter F, Lorenz W, Regensburg QoL Study Group (2012) Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer 106:826–838CrossRef Klinkhammer-Schalke M, Koller M, Steinger B, Ehret C, Ernst B, Wyatt JC, Hofstadter F, Lorenz W, Regensburg QoL Study Group (2012) Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer 106:826–838CrossRef
21.
go back to reference Carlson LE, Groff SL, Maciejewski O, Bultz BD (2010) Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol 28:4884–4891CrossRef Carlson LE, Groff SL, Maciejewski O, Bultz BD (2010) Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol 28:4884–4891CrossRef
22.
go back to reference Girgis A, Breen S, Stacey F, Lecathelinais C (2009) Impact of two supportive care interventions on anxiety, depression, quality of life, and unmet needs in patients with nonlocalized breast and colorectal cancers. J Clin Oncol 27:6180–6190CrossRef Girgis A, Breen S, Stacey F, Lecathelinais C (2009) Impact of two supportive care interventions on anxiety, depression, quality of life, and unmet needs in patients with nonlocalized breast and colorectal cancers. J Clin Oncol 27:6180–6190CrossRef
23.
go back to reference Donovan KA, Grassi L, McGinty HL, Jacobsen PB (2014) Validation of the distress thermometer worldwide: state of the science. Psychooncology 23:241–250CrossRef Donovan KA, Grassi L, McGinty HL, Jacobsen PB (2014) Validation of the distress thermometer worldwide: state of the science. Psychooncology 23:241–250CrossRef
24.
go back to reference Bloom JR, Petersen DM, Kang SH (2007) Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology 16:691–706CrossRef Bloom JR, Petersen DM, Kang SH (2007) Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology 16:691–706CrossRef
25.
go back to reference Lester J, Crosthwaite K, Stout R, Jones RN, Holloman C, Shapiro C, Andersen BL (2015) Women with breast cancer: self-reported distress in early survivorship. Oncol Nurs Forum 42:E17–E23CrossRef Lester J, Crosthwaite K, Stout R, Jones RN, Holloman C, Shapiro C, Andersen BL (2015) Women with breast cancer: self-reported distress in early survivorship. Oncol Nurs Forum 42:E17–E23CrossRef
26.
go back to reference McFarland DC, Shaffer KM, Tiersten A, Holland J (2018) Prevalence of physical problems detected by the distress thermometer and problem list in patients with breast cancer. Psychooncology 27:1394–1403CrossRef McFarland DC, Shaffer KM, Tiersten A, Holland J (2018) Prevalence of physical problems detected by the distress thermometer and problem list in patients with breast cancer. Psychooncology 27:1394–1403CrossRef
27.
go back to reference Ploos van Amstel FK, van den Berg SW, van Laarhoven HW, Gielissen MF, Prins JB, Ottevanger PB (2013) Distress screening remains important during follow-up after primary breast cancer treatment. Support Care Cancer 21:2107–2115CrossRef Ploos van Amstel FK, van den Berg SW, van Laarhoven HW, Gielissen MF, Prins JB, Ottevanger PB (2013) Distress screening remains important during follow-up after primary breast cancer treatment. Support Care Cancer 21:2107–2115CrossRef
28.
go back to reference Bidstrup PE, Christensen J, Mertz BG, Rottmann N, Dalton SO, Johansen C (2015) Trajectories of distress, anxiety, and depression among women with breast cancer: looking beyond the mean. Acta Oncol 54:789–796CrossRef Bidstrup PE, Christensen J, Mertz BG, Rottmann N, Dalton SO, Johansen C (2015) Trajectories of distress, anxiety, and depression among women with breast cancer: looking beyond the mean. Acta Oncol 54:789–796CrossRef
29.
go back to reference Garson GD (2015) Missing values analysis and data imputation. Statistical Associates Publishers, Asheboro Garson GD (2015) Missing values analysis and data imputation. Statistical Associates Publishers, Asheboro
30.
go back to reference van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16:219–242CrossRef van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16:219–242CrossRef
31.
go back to reference Field AP (2009) Discovering statistics using SPSS: (and sex and drugs and rock ‘n’ roll). SAGE Publications, London Field AP (2009) Discovering statistics using SPSS: (and sex and drugs and rock ‘n’ roll). SAGE Publications, London
32.
go back to reference Kim HY (2017) Statistical notes for clinical researchers: chi-squared test and Fisher’s exact test. Restor Dent Endod 42:152–155CrossRef Kim HY (2017) Statistical notes for clinical researchers: chi-squared test and Fisher’s exact test. Restor Dent Endod 42:152–155CrossRef
33.
go back to reference Koeter MWJ, Ormel J (1991) Nederlandse bewerking en handleiding. [general health questionnaire: Dutch edition and manual]. Swets & Zeitlinger, Lisse Koeter MWJ, Ormel J (1991) Nederlandse bewerking en handleiding. [general health questionnaire: Dutch edition and manual]. Swets & Zeitlinger, Lisse
34.
go back to reference van Scheppingen C, Schroevers MJ, Smink A, van der Linden YM, Mul VE, Langendijk JA, Coyne JC, Sanderman R (2011) Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psychooncology 20:655–663CrossRef van Scheppingen C, Schroevers MJ, Smink A, van der Linden YM, Mul VE, Langendijk JA, Coyne JC, Sanderman R (2011) Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psychooncology 20:655–663CrossRef
35.
go back to reference Kootstra J, Hoekstra-Weebers JE, Rietman H, de Vries J, Baas P, Geertzen JH, Hoekstra HJ (2008) Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol 15:2533–2541CrossRef Kootstra J, Hoekstra-Weebers JE, Rietman H, de Vries J, Baas P, Geertzen JH, Hoekstra HJ (2008) Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol 15:2533–2541CrossRef
36.
go back to reference Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27:390–397CrossRef Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27:390–397CrossRef
37.
go back to reference Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM (2007) The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomark Prev 16:775–782CrossRef Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM (2007) The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomark Prev 16:775–782CrossRef
38.
go back to reference Faller H, Weis J, Koch U, Brahler E, Harter M, Keller M, Schulz H, Wegscheider K, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Wittchen HU, Mehnert A (2017) Utilization of professional psychological care in a large German sample of cancer patients. Psychooncology 26:537–543CrossRef Faller H, Weis J, Koch U, Brahler E, Harter M, Keller M, Schulz H, Wegscheider K, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Wittchen HU, Mehnert A (2017) Utilization of professional psychological care in a large German sample of cancer patients. Psychooncology 26:537–543CrossRef
39.
go back to reference Graves KD, Arnold SM, Love CL, Kirsh KL, Moore PG, Passik SD (2007) Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer 55:215–224CrossRef Graves KD, Arnold SM, Love CL, Kirsh KL, Moore PG, Passik SD (2007) Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer 55:215–224CrossRef
Metadata
Title
Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completion
Authors
J. M. Admiraal
J. E. H. M. Hoekstra-Weebers
C. P. Schröder
W. Tuinier
G. A. P. Hospers
Anna K. L. Reyners
Publication date
01-07-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 7/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05030-6

Other articles of this Issue 7/2020

Supportive Care in Cancer 7/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine